199 related articles for article (PubMed ID: 8502227)
1. Variation in human thymidylate synthase is associated with resistance to 5-fluoro-2'-deoxyuridine.
Davis ST; Berger SH
Mol Pharmacol; 1993 May; 43(5):702-8. PubMed ID: 8502227
[TBL] [Abstract][Full Text] [Related]
2. Modulation of 5-fluoro-2'-deoxyuridine response by folinic acid in human colonic tumor cell lines: the role of thymidylate synthase.
Davis ST; Berger SH
Mol Pharmacol; 1989 Apr; 35(4):422-7. PubMed ID: 2523018
[TBL] [Abstract][Full Text] [Related]
3. Thymidylate synthase as a determinant of 5-fluoro-2'-deoxyuridine response in human colonic tumor cell lines.
Berger SH; Berger FG
Mol Pharmacol; 1988 Oct; 34(4):474-9. PubMed ID: 2971871
[TBL] [Abstract][Full Text] [Related]
4. A naturally occurring variation in thymidylate synthase structure is associated with a reduced response to 5-fluoro-2'-deoxyuridine in a human colon tumor cell line.
Berger SH; Barbour KW; Berger FG
Mol Pharmacol; 1988 Oct; 34(4):480-4. PubMed ID: 2971872
[TBL] [Abstract][Full Text] [Related]
5. Functional effects of a naturally occurring amino acid substitution in human thymidylate synthase.
Hughey CT; Barbour KW; Berger FG; Berger SH
Mol Pharmacol; 1993 Aug; 44(2):316-23. PubMed ID: 8355668
[TBL] [Abstract][Full Text] [Related]
6. Biphasic binding of 5-fluoro-2'-deoxyuridylate to human thymidylate synthase.
Reilly RT; Barbour KW; Dunlap RB; Berger FG
Mol Pharmacol; 1995 Jul; 48(1):72-9. PubMed ID: 7623777
[TBL] [Abstract][Full Text] [Related]
7. Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studies.
Jackman AL; Alison DL; Calvert AH; Harrap KR
Cancer Res; 1986 Jun; 46(6):2810-5. PubMed ID: 2938731
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation in thymidylate synthase confers resistance to 5-fluorodeoxyuridine.
Hughey CT; Barbour KW; Berger FG; Berger SH
Adv Exp Med Biol; 1993; 339():67-76. PubMed ID: 8178730
[TBL] [Abstract][Full Text] [Related]
9. Human leukemic cells resistant to 5-fluoro-2'-deoxyuridine contain a thymidylate synthetase with lower affinity for nucleotides.
Bapat AR; Zarow C; Danenberg PV
J Biol Chem; 1983 Apr; 258(7):4130-6. PubMed ID: 6220000
[TBL] [Abstract][Full Text] [Related]
10. Kinetic studies on drug-resistant variants of Escherichia coli thymidylate synthase: functional effects of amino acid substitutions at residue 4.
Mahdavian E; Spencer HT; Dunlap RB
Arch Biochem Biophys; 1999 Aug; 368(2):257-64. PubMed ID: 10441376
[TBL] [Abstract][Full Text] [Related]
11. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.
van Triest B; Pinedo HM; van Hensbergen Y; Smid K; Telleman F; Schoenmakers PS; van der Wilt CL; van Laar JA; Noordhuis P; Jansen G; Peters GJ
Clin Cancer Res; 1999 Mar; 5(3):643-54. PubMed ID: 10100718
[TBL] [Abstract][Full Text] [Related]
12. Thymidylate synthase overproduction and gene amplification in fluorodeoxyuridine-resistant human cells.
Berger SH; Jenh CH; Johnson LF; Berger FG
Mol Pharmacol; 1985 Nov; 28(5):461-7. PubMed ID: 2932632
[TBL] [Abstract][Full Text] [Related]
13. Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the National Cancer Institute's Anticancer Drug Screen.
Grem JL; Danenberg KD; Behan K; Parr A; Young L; Danenberg PV; Nguyen D; Drake J; Monks A; Allegra CJ
Clin Cancer Res; 2001 Apr; 7(4):999-1009. PubMed ID: 11309351
[TBL] [Abstract][Full Text] [Related]
14. Functional effects of amino acid substitutions at residue 33 of human thymidylate synthase.
Reilly RT; Forsthoefel AM; Berger FG
Arch Biochem Biophys; 1997 Jun; 342(2):338-43. PubMed ID: 9186496
[TBL] [Abstract][Full Text] [Related]
15. Novel mechanism(s) of resistance to 5-fluorouracil in human colon cancer (HCT-8) sublines following exposure to two different clinically relevant dose schedules.
Aschele C; Sobrero A; Faderan MA; Bertino JR
Cancer Res; 1992 Apr; 52(7):1855-64. PubMed ID: 1532346
[TBL] [Abstract][Full Text] [Related]
16. The role of thymidylate synthase in the response to fluoropyrimidine-folinic acid combinations.
Berger SH; Davis ST; Barbour KW; Berger FG
Adv Exp Med Biol; 1988; 244():59-69. PubMed ID: 2977716
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of a human ileocecal carcinoma cell line (HCT-8) subclone resistant to fluorodeoxyuridine.
Zhang ZG; Malmberg M; Yin MB; Slocum HK; Rustum YM
Biochem Pharmacol; 1993 Mar; 45(5):1157-64. PubMed ID: 8461045
[TBL] [Abstract][Full Text] [Related]
18. Defective facilitated diffusion of nucleosides, a primary mechanism of resistance to 5-fluoro-2'-deoxyuridine in the HCT-8 human carcinoma line.
Sobrero AF; Moir RD; Bertino JR; Handschumacher RE
Cancer Res; 1985 Jul; 45(7):3155-60. PubMed ID: 3159474
[TBL] [Abstract][Full Text] [Related]
19. Creation and characterization of 5-fluorodeoxyuridine-resistant Arg50 loop mutants of human thymidylate synthase.
Landis DM; Heindel CC; Loeb LA
Cancer Res; 2001 Jan; 61(2):666-72. PubMed ID: 11212266
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of 5-fluoro-2'-deoxyuridine antineoplastic activity by 5-benzyloxybenzyloxybenzylacyclouridine in a human colon carcinoma cell line.
Chu E; Chu MY; Darnowski JW; Chen ZH; Pan BC; Chu SH
Cancer Res; 1992 Apr; 52(7):1729-36. PubMed ID: 1532344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
